Application Proof

	NeuroGen Pharma Limited
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

► WARNING ► IMPORTANT ► EXPECTED TIMETABLE ► CONTENTS ► SUMMARY ► DEFINITIONS ► GLOSSARY OF TECHNICAL TERMS ► FORWARD-LOOKING STATEMENTS ► RISK FACTORS ► WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES ► INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED] ► DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED] ► CORPORATE INFORMATION ► INDUSTRY OVERVIEW ► REGULATORY OVERVIEW ► HISTORY AND CORPORATE STRUCTURE ► BUSINESS ► RELATIONSHIP WITH OUR CONTROLLING SHAREHOLDERS ► DIRECTORS AND SENIOR MANAGEMENT ► SUBSTANTIAL SHAREHOLDERS ► SHARE CAPITAL ► FINANCIAL INFORMATION ► FUTURE PLANS AND [REDACTED] ► [REDACTED] ► STRUCTURE OF THE [REDACTED] ► HOW TO APPLY FOR [REDACTED] ► APPENDIX IA - ACCOUNTANTS' REPORT OF THE GROUP ► APPENDIX IB - ACCOUNTANTS' REPORT OF NEUROGEN ZHUHAI FOR THE YEARS ENDED DECEMBER 31, 2023, 2024 AND 2025 ► APPENDIX IC - ACCOUNTANTS' REPORT OF THE PRE ACQUISITION FINANCIAL INFORMATION OF NEUROGEN ZHUHAI ► APPENDIX II - UNAUDITED [REDACTED] FINANCIAL INFORMATION ► APPENDIX III - SUMMARY OF THE CONSTITUTION OF OUR COMPANY AND CAYMAN ISLANDS COMPANY LAW ► APPENDIX IV - BIOGRAPHICAL DETAILS OF THE MEMBERS OF THE NEUROGEN ZHUHAI MANAGEMENT TEAM ► APPENDIX V - STATUTORY AND GENERAL INFORMATION ► APPENDIX VI - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES AND AVAILABLE ON DISPLAY